{"product_id":"health-risk-assessment-for-asbestos-and-other-fibrous-minerals-hardback-9781119438434","title":"Health Risk Assessment for Asbestos and Other Fibrous Minerals (Hardback) 9781119438434","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eHealth Risk Assessment for Asbestos and Other Fibrous Minerals\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cfont size=\"4\"\u003eAndrey Korchevskiy (Edited by), A Korchevskiy (Author), James Rasmuson (Edited by), Eric Rasmuson (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9781119438434, Wiley\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 4 July 2024\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e480 pages\u003cbr\u003e22.9 x 15.2 x 2.9 cm, 1.22 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003cb\u003eEvaluates the risks and human health impacts of asbestos and other fibrous minerals\u003c\/b\u003e \u003c\/p\u003e\n\u003cp\u003eDespite continuous efforts to eliminate asbestos from commercial use, it remains a serious occupational and environmental hazard. \u003ci\u003eHealth Risk Assessment for Asbestos and Other Fibrous Minerals\u003c\/i\u003e provides a rigorous discussion of risk assessment methodology for elongate mineral particles, covering basics, theory, models, and practical applications, enabling readers to participate in carrying out efficient and informed health risk assessments, to estimate potential adverse effects for exposed populations, and to determine the acceptability of risks at a given level of exposure. \u003c\/p\u003e\n\u003cp\u003eCoverage includes: \u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eMineralogy, health effects, pathology, exposure assessment, modeling, and characterization of risks for asbestos and similar toxic materials\u003c\/li\u003e\n\u003cli\u003eNecessary integration of epidemiology, toxicology, industrial hygiene, and environmental health expertise when performing a health risk assessment\u003c\/li\u003e\n\u003cli\u003eEmerging and not-well-known hazards, e.g. erionite and other naturally occurring fibrous minerals\u003c\/li\u003e\n\u003cli\u003eContributions by Garry Burdett, Bruce Case, Lucy Darnton, Daniel Hall, Arseniy Korchevskiy, Brooke Mossman, Cassidy Strode, Robert Strode, and Ann Wylie\u003c\/li\u003e\n\u003cli\u003eCase studies and examples of risk calculations\u003c\/li\u003e\n\u003c\/ul\u003e \u003cp\u003e\u003ci\u003eHealth Risk Assessment for Asbestos and Other Fibrous Minerals\u003c\/i\u003e is a highly practical reference on the subject for occupational and public health professionals, industry and government regulators, industrial hygienists, and risk assessors, along with epidemiologists, biostatisticians, toxicologists, and other scientific professionals.\u003c\/p\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eList of Contributors xv\u003c\/p\u003e \u003cp\u003ePreface xvii\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart I Hazard Identification 1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 Mineralogical Characteristics and Risk Assessment of Elongate Mineral Particles (EMPs): Asbestos, Fiber, and Fragment 3\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eAnn G. Wylie\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 3\u003c\/p\u003e \u003cp\u003eNomenclature 6\u003c\/p\u003e \u003cp\u003eSource Specificity: Chemical and Physical Properties 8\u003c\/p\u003e \u003cp\u003eSource Specificity: Dimension 11\u003c\/p\u003e \u003cp\u003eStructural Groupings of Common Elongate Minerals 13\u003c\/p\u003e \u003cp\u003eEstablishing the Chemical Composition of Minerals 15\u003c\/p\u003e \u003cp\u003eMineral Intergrowths and Associations 16\u003c\/p\u003e \u003cp\u003eBioreactivity of Mineral Surfaces: Chemical Factors 17\u003c\/p\u003e \u003cp\u003eThe Specificity of Mineral Surfaces: The Example of Quartz 17\u003c\/p\u003e \u003cp\u003eGeneral Considerations of Solubility 18\u003c\/p\u003e \u003cp\u003eFormation of Reactive Oxygen Species (ROS) 20\u003c\/p\u003e \u003cp\u003eCoatings 21\u003c\/p\u003e \u003cp\u003eSurface Charge 22\u003c\/p\u003e \u003cp\u003eEMP Surfaces: Chain Silicates and Zeolites 23\u003c\/p\u003e \u003cp\u003ePhysical Factors 24\u003c\/p\u003e \u003cp\u003eSpecific Surface Area 24\u003c\/p\u003e \u003cp\u003eEnthalpy and Other Thermodynamic Properties 26\u003c\/p\u003e \u003cp\u003eDensity and Aerodynamic Diameter 26\u003c\/p\u003e \u003cp\u003eStiffness and Tensile Strength 28\u003c\/p\u003e \u003cp\u003eThe Effects of Heat 30\u003c\/p\u003e \u003cp\u003eDimensionality: General Considerations 30\u003c\/p\u003e \u003cp\u003eEstablishing Measurement Protocols 32\u003c\/p\u003e \u003cp\u003eOptical vs. Electron Microscopy Methods 32\u003c\/p\u003e \u003cp\u003eStratified Counting 34\u003c\/p\u003e \u003cp\u003eSample Preparation for TEM: Direct vs. Indirect Preparation 34\u003c\/p\u003e \u003cp\u003eFrequency Distributions of Length and Width 35\u003c\/p\u003e \u003cp\u003eLung Burden 37\u003c\/p\u003e \u003cp\u003eDimensionality and Carcinogenicity 38\u003c\/p\u003e \u003cp\u003eDiscussion 39\u003c\/p\u003e \u003cp\u003eReferences 40\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 Toxicology of Mineral Fibers and Implications for Risk Assessment 52\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eBrooke T. Mossman\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 52\u003c\/p\u003e \u003cp\u003eUse of Rodent Models to Analyze the Toxicity to Disease Potential of Naturally Occurring and Synthetic Fibers 53\u003c\/p\u003e \u003cp\u003eInhalation Studies 53\u003c\/p\u003e \u003cp\u003eIntratracheal Instillation and Oropharyngeal Aspiration Studies 54\u003c\/p\u003e \u003cp\u003eIntrapleural Injection Studies 54\u003c\/p\u003e \u003cp\u003eIntraperitoneal Injection Studies 54\u003c\/p\u003e \u003cp\u003eComparative Results on Effects of Asbestos and Other Naturally Occurring Fibers in Rodent Studies 54\u003c\/p\u003e \u003cp\u003eIn vitro Models of Toxicity 66\u003c\/p\u003e \u003cp\u003eAdvantages and Disadvantage of In vitro Models 66\u003c\/p\u003e \u003cp\u003eContributions of In vitro Models to Understanding Mechanisms of Cytotoxicity and Carcinogenesis by Mineral Fibers 67\u003c\/p\u003e \u003cp\u003eProperties of Mineral Fibers Important in Toxicity and Carcinogenic Effects 68\u003c\/p\u003e \u003cp\u003eA Systems Biology Approach to Understanding Connections and Interactions Between Adverse Outcomes in Mineral Fiber-Induced Diseases 71\u003c\/p\u003e \u003cp\u003eReferences 72\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 Health Outcomes of Asbestos Exposure – A Pathology and Diagnostic Perspective 82\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eBruce Case\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 82\u003c\/p\u003e \u003cp\u003eNonmalignant Change in Structure or Function 83\u003c\/p\u003e \u003cp\u003eNonmalignant Asbestos-Related Disease 84\u003c\/p\u003e \u003cp\u003ePleural 84\u003c\/p\u003e \u003cp\u003eAsbestos Effusion 84\u003c\/p\u003e \u003cp\u003ePleural Plaques and Localized Pleural Thickening (LPT) 84\u003c\/p\u003e \u003cp\u003eDiffuse Pleural Thickening 88\u003c\/p\u003e \u003cp\u003eRounded Atelectasis 89\u003c\/p\u003e \u003cp\u003eLung 89\u003c\/p\u003e \u003cp\u003eAsbestosis 89\u003c\/p\u003e \u003cp\u003eMalignant Diseases Attributable to Asbestos Exposure 92\u003c\/p\u003e \u003cp\u003eGeneral Comments 92\u003c\/p\u003e \u003cp\u003eAsbestos-Related Lung Cancer 94\u003c\/p\u003e \u003cp\u003eMesothelioma – Accelerating Knowledge 96\u003c\/p\u003e \u003cp\u003eReferences 102\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart II Exposure Assessment 109\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 Principles of Exposure Assessment for Elongate Mineral Particles (EMPs) 111\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eEric Rasmuson, James Rasmuson, and Andrey Korchevskiy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eGeneral Principles and Methods 113\u003c\/p\u003e \u003cp\u003eGathering Information 113\u003c\/p\u003e \u003cp\u003eEvaluating the Quality of Data 114\u003c\/p\u003e \u003cp\u003eMeasurement Techniques 116\u003c\/p\u003e \u003cp\u003eComparison of the Results of Different Analytical Methodologies 120\u003c\/p\u003e \u003cp\u003eProximity to the Emission Source 121\u003c\/p\u003e \u003cp\u003eAdjusting Results for Censored Data 122\u003c\/p\u003e \u003cp\u003eCorrelation of EMP Exposures and Lung Burden Analysis 122\u003c\/p\u003e \u003cp\u003eReferences 123\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 Asbestos Exposure Measurements: Principles of Current and Historical Data Interpretation 127\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eGarry Burdett\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eAim and Background 127\u003c\/p\u003e \u003cp\u003eCauses of Asbestos-Related Lung Disease and Their Relationship to Exposure Assessment 128\u003c\/p\u003e \u003cp\u003eExposure Measurement 130\u003c\/p\u003e \u003cp\u003eHistoric Methods of Asbestos Exposure Measurement 131\u003c\/p\u003e \u003cp\u003eGravimetric Methods 131\u003c\/p\u003e \u003cp\u003eImpaction Sampling and Microscopic Particle Counting 132\u003c\/p\u003e \u003cp\u003eImpinger Sampling and Microscopic Particle Counting 132\u003c\/p\u003e \u003cp\u003eThermal Precipitator (TP) Sampling and Microscopic Particle Counting 133\u003c\/p\u003e \u003cp\u003eDirect Reading Instruments for Particle and Fiber Counting 134\u003c\/p\u003e \u003cp\u003eEarly Sampling Strategies 135\u003c\/p\u003e \u003cp\u003eDevelopment of the Current Analytical Methods for Fiber Counting 136\u003c\/p\u003e \u003cp\u003eMembrane Filter Sampling and Phase Contrast Microscopy Fiber Counting (MF-PCM) 136\u003c\/p\u003e \u003cp\u003eMembrane Filter Sampling and Electron Microscopy (EM) Analysis 137\u003c\/p\u003e \u003cp\u003eLimitations of Current Indices of Exposure Assessment 139\u003c\/p\u003e \u003cp\u003eVariability of the MF-PCM Index Over Time 140\u003c\/p\u003e \u003cp\u003eSampling Method 140\u003c\/p\u003e \u003cp\u003eSample Preparation 141\u003c\/p\u003e \u003cp\u003eMicroscope Equipment and Set-Up 142\u003c\/p\u003e \u003cp\u003eFiber Definition 143\u003c\/p\u003e \u003cp\u003eCounting Procedures and Performance 144\u003c\/p\u003e \u003cp\u003eEffect of Changes to the MF-PCM Counts Over Time 145\u003c\/p\u003e \u003cp\u003eConclusion 146\u003c\/p\u003e \u003cp\u003eAcknowledgements 147\u003c\/p\u003e \u003cp\u003eReferences 147\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 Asbestos Exposure Modeling Using Advanced Tools Including Computational Fluid Dynamics (CFD) 153\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eDaniel Hall, James Rasmuson, and Cassidy Strode\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 153\u003c\/p\u003e \u003cp\u003eValidation and Application of CFD Air Dispersion Modeling 155\u003c\/p\u003e \u003cp\u003eOverview of CFD General Methodology 157\u003c\/p\u003e \u003cp\u003eCFD Simulation Set-Up 159\u003c\/p\u003e \u003cp\u003eGeometry Creation and Set-Up 159\u003c\/p\u003e \u003cp\u003eMesh Creation 160\u003c\/p\u003e \u003cp\u003eParameter Set-Up 160\u003c\/p\u003e \u003cp\u003eComputational Solve 162\u003c\/p\u003e \u003cp\u003ePost-processing 162\u003c\/p\u003e \u003cp\u003eComplementary Modeling Software Tools 163\u003c\/p\u003e \u003cp\u003eOther Software Tools 164\u003c\/p\u003e \u003cp\u003eIndoor and Outdoor Modeling Examples 164\u003c\/p\u003e \u003cp\u003eFirst Example – Indoor CFD Modeling 164\u003c\/p\u003e \u003cp\u003ePreliminary Outdoor CFD Wind Simulation – Effect on Indoor Ventilation 166\u003c\/p\u003e \u003cp\u003eIndoor CFD Simulations 168\u003c\/p\u003e \u003cp\u003eMill Ventilation 168\u003c\/p\u003e \u003cp\u003eOther Model Parameters 169\u003c\/p\u003e \u003cp\u003eSource Descriptions 170\u003c\/p\u003e \u003cp\u003eReheat Furnace Brick Removal Source 170\u003c\/p\u003e \u003cp\u003ePipe Insulation Removal Source 171\u003c\/p\u003e \u003cp\u003eCFD Results 172\u003c\/p\u003e \u003cp\u003eSecond Example – Outdoor CFD, AERMOD, and CALPUFF Models 174\u003c\/p\u003e \u003cp\u003eModel Geometry 177\u003c\/p\u003e \u003cp\u003eReceptor Descriptions 177\u003c\/p\u003e \u003cp\u003eSource Descriptions 177\u003c\/p\u003e \u003cp\u003eFugitive Plant Emission – Manufacturing, Finishing, Fiber Warehouse, Tray Loading, and Stripping Station 180\u003c\/p\u003e \u003cp\u003eBaghouse Source Emission Rates 182\u003c\/p\u003e \u003cp\u003ePipe Storage and Shipping Yard Source Emission Rate 183\u003c\/p\u003e \u003cp\u003eCrusher Source Emission Rate 183\u003c\/p\u003e \u003cp\u003eMeteorology 184\u003c\/p\u003e \u003cp\u003eCFD Results 186\u003c\/p\u003e \u003cp\u003eEPA Outdoor Dispersion Models 188\u003c\/p\u003e \u003cp\u003eGeophysical Set-Up 188\u003c\/p\u003e \u003cp\u003eCALMET Set-Up 189\u003c\/p\u003e \u003cp\u003eCALPUFF Processor 189\u003c\/p\u003e \u003cp\u003eCALPUFF Results 191\u003c\/p\u003e \u003cp\u003eAERMOD Model 191\u003c\/p\u003e \u003cp\u003eGeophysical Set-Up 191\u003c\/p\u003e \u003cp\u003eMeteorology Set-Up 191\u003c\/p\u003e \u003cp\u003eAERMOD Set-Up 193\u003c\/p\u003e \u003cp\u003eAERMOD Results 194\u003c\/p\u003e \u003cp\u003eComparison of CFD, CALPUFF, and AERMOD Results 194\u003c\/p\u003e \u003cp\u003eDiscussion and Conclusions 194\u003c\/p\u003e \u003cp\u003eReferences 197\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart III Dose-Response Assessment 201\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Asbestos Dose–Response Assessment: The Peto Model and Its Application in the US EPA and Berman and Crump Studies 203\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eAndrey Korchevskiy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eRationale and Meaning of the Peto Model 203\u003c\/p\u003e \u003cp\u003eUtilization of the Peto Model by the US EPA 212\u003c\/p\u003e \u003cp\u003eBerman and Crump Meta-analysis Based on Peto Model 218\u003c\/p\u003e \u003cp\u003eReferences 228\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 The Hodgson and Darnton Approach to Quantifying the Risks of Mesothelioma and Lung Cancer in Relation to Asbestos Exposure 233\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eLucy Darnton\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 233\u003c\/p\u003e \u003cp\u003eOverview of the Hodgson and Darnton Approach 234\u003c\/p\u003e \u003cp\u003eMetrics and Data Requirements 235\u003c\/p\u003e \u003cp\u003eLung Cancer 235\u003c\/p\u003e \u003cp\u003eMesothelioma 236\u003c\/p\u003e \u003cp\u003eOther Data Issues 236\u003c\/p\u003e \u003cp\u003eSummary of Cohorts Included in the Original and Updated Meta-Analyses 237\u003c\/p\u003e \u003cp\u003eCrocidolite Cohorts 238\u003c\/p\u003e \u003cp\u003eAmosite Cohorts 239\u003c\/p\u003e \u003cp\u003eOther Amphiboles: Vermiculite Miners and Associated Workers, Libby, Montana, USA 241\u003c\/p\u003e \u003cp\u003eChrysotile Cohorts 242\u003c\/p\u003e \u003cp\u003eSummary of Original and Updated Meta-Analyses 245\u003c\/p\u003e \u003cp\u003eMesothelioma 245\u003c\/p\u003e \u003cp\u003eLung Cancer 250\u003c\/p\u003e \u003cp\u003eNonlinear Exposure–Response Relationship 256\u003c\/p\u003e \u003cp\u003ePleural Mesothelioma 257\u003c\/p\u003e \u003cp\u003ePeritoneal Mesothelioma 259\u003c\/p\u003e \u003cp\u003eLung Cancer 260\u003c\/p\u003e \u003cp\u003eSummary 262\u003c\/p\u003e \u003cp\u003eApplication of Hodgson and Darnton for Risk Assessment 262\u003c\/p\u003e \u003cp\u003eConclusions 264\u003c\/p\u003e \u003cp\u003eReferences 266\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9 Prediction of Mesothelioma Mortality in the Context of Country-wide Risk Evaluation 270\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eLucy Darnton\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eConclusions 284\u003c\/p\u003e \u003cp\u003eReferences 284\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10 Implications of Exposure Measurement Methodologies for Dose–Response Assessment in Asbestos Worker Cohorts 286\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eGarry Burdett\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eElectron Microscopy Fiber Size Distribution for Different Cohorts and Their Relationship to PCM Fiber Counts 287\u003c\/p\u003e \u003cp\u003eTEM Fiber-Size-Distribution in Cohorts from Mines and Mills 288\u003c\/p\u003e \u003cp\u003eTEM Size Distributions from Manufacturing Cohorts 289\u003c\/p\u003e \u003cp\u003eSEM Size Distributions from Manufacturing Cohorts 292\u003c\/p\u003e \u003cp\u003eEM Determinations of Asbestos Fiber Types in Asbestos Industry Cohorts 293\u003c\/p\u003e \u003cp\u003eNatural Occurrence 294\u003c\/p\u003e \u003cp\u003eMixed-Use 295\u003c\/p\u003e \u003cp\u003eExternal Sources 296\u003c\/p\u003e \u003cp\u003eLung Burden Analysis 296\u003c\/p\u003e \u003cp\u003eConversions of Historic Cohort Measurement Indices to MF-PCM Fiber Counts 296\u003c\/p\u003e \u003cp\u003eConversion from Impinger Counts to MF-PCM 297\u003c\/p\u003e \u003cp\u003eConversions from Other Particle Counting Methods 299\u003c\/p\u003e \u003cp\u003eConversions from Gravimetric Measurement 299\u003c\/p\u003e \u003cp\u003eCrocidolite Cohort Exposures 302\u003c\/p\u003e \u003cp\u003eWittenoom Occupational 302\u003c\/p\u003e \u003cp\u003eWittenoom Environmental 305\u003c\/p\u003e \u003cp\u003eSouth African Mines and Mills 306\u003c\/p\u003e \u003cp\u003eMassachusetts Cigarette Filter Manufacturing 309\u003c\/p\u003e \u003cp\u003eUK Gas Mask Workers 310\u003c\/p\u003e \u003cp\u003eOther Cohorts Exposed to Crocidolite 311\u003c\/p\u003e \u003cp\u003eCrocidolite Summary 311\u003c\/p\u003e \u003cp\u003eAmosite Cohort Exposures 311\u003c\/p\u003e \u003cp\u003eSouth African Amosite Mining 311\u003c\/p\u003e \u003cp\u003ePatterson, New Jersey 314\u003c\/p\u003e \u003cp\u003eTyler, Texas 315\u003c\/p\u003e \u003cp\u003eUxbridge 315\u003c\/p\u003e \u003cp\u003eAmosite Summary 316\u003c\/p\u003e \u003cp\u003eChrysotile Mining and Milling Cohort Exposures 317\u003c\/p\u003e \u003cp\u003eQuebec, Canada 318\u003c\/p\u003e \u003cp\u003eBalangero, Italy 318\u003c\/p\u003e \u003cp\u003eQinghai, China 319\u003c\/p\u003e \u003cp\u003eUralasbest, Russia 321\u003c\/p\u003e \u003cp\u003eChrysotile Mining Summary 322\u003c\/p\u003e \u003cp\u003eChrysotile Textiles 322\u003c\/p\u003e \u003cp\u003eSouth Carolina Textile Workers 324\u003c\/p\u003e \u003cp\u003eNorth Carolina Textile Workers 325\u003c\/p\u003e \u003cp\u003eChongqing Chrysotile Cohort 327\u003c\/p\u003e \u003cp\u003eChrysotile Textiles Summary 328\u003c\/p\u003e \u003cp\u003eOther Chrysotile Cohorts 328\u003c\/p\u003e \u003cp\u003eDiscussion and Outlook 330\u003c\/p\u003e \u003cp\u003eAcknowledgement 333\u003c\/p\u003e \u003cp\u003eReferences 333\u003c\/p\u003e \u003cp\u003e\u003cb\u003e11 Mathematical Modeling of Cancer Potency for Various Fibrous Minerals 344\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eAndrey Korchevskiy, James Rasmuson, and Eric Rasmuson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eReferences 360\u003c\/p\u003e \u003cp\u003e\u003cb\u003e12 Theoretical and Practical Aspects of Asbestos Dose–Response Assessment 366\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eAndrey Korchevskiy and James Rasmuson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eGeneral Considerations and Model of Asbestos Dose–Response Assessment 366\u003c\/p\u003e \u003cp\u003eLinear Model 367\u003c\/p\u003e \u003cp\u003eNonlinear Model 368\u003c\/p\u003e \u003cp\u003eRelationship Between Different Estimation of Mesothelioma and Lung Cancer Potency Factors 371\u003c\/p\u003e \u003cp\u003eLife Tables and Life Expectancy of the Exposed Population 374\u003c\/p\u003e \u003cp\u003eLinearity and Nonlinearity of the Dose–Response Curves 375\u003c\/p\u003e \u003cp\u003eThreshold and Benchmark Dose Response in Asbestos Risk Assessment 376\u003c\/p\u003e \u003cp\u003eCommunity and Occupational Risk Assessment 378\u003c\/p\u003e \u003cp\u003ePeritoneal Mesothelioma 378\u003c\/p\u003e \u003cp\u003eOther Types of Cancer 380\u003c\/p\u003e \u003cp\u003eInhalation Unit Risk (IUR) for Asbestos Fibers 383\u003c\/p\u003e \u003cp\u003eAsbestos Dose–Response and Tobacco Smoking 385\u003c\/p\u003e \u003cp\u003eOther Factors Impacting the Dose–Response Relationship for Elongate Mineral Particles 387\u003c\/p\u003e \u003cp\u003eReferences 388\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart IV Risk Characterization 393\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e13 Risk Characterization for Occupational and Environmental Exposure to Asbestos: Case Studies 395\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eJames Rasmuson, Andrey Korchevskiy, and Eric Rasmuson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eReferences 408\u003c\/p\u003e \u003cp\u003e\u003cb\u003e14 Asbestos in Soil: Risk Characterization for Occupational and Environmental Exposures 412\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eAndrey Korchevskiy and Robert Strode\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eReferences 424\u003c\/p\u003e \u003cp\u003e\u003cb\u003e15 Asbestos in Brakes: Risk Assessment for Exposure Patterns with Nonlinear Dynamics 427\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eAndrey Korchevskiy, Robert Strode, and Arseniy Korchevskiy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eAmbient Air Emissions from the Brakes in Street Canyons 428\u003c\/p\u003e \u003cp\u003eFibers in Car Brakes: Chaotic Behavior of Emissions in a Self-regulated Community 433\u003c\/p\u003e \u003cp\u003eDiagnosing the Chaotic Trends 439\u003c\/p\u003e \u003cp\u003eReferences 441\u003c\/p\u003e \u003cp\u003eIndex 443\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Chemistry [\u003ca title=\"See our other books on Chemistry\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Chemistry%20%5BPN%5D%22\"\u003ePN\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Wiley","offers":[{"title":"Brand New","offer_id":52165306679576,"sku":"9781119438434","price":122.19,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/files\/9781119438434.jpg?v=1781098159","url":"https:\/\/freshlyprintedbooks.co.uk\/products\/health-risk-assessment-for-asbestos-and-other-fibrous-minerals-hardback-9781119438434","provider":"Freshly Printed Books","version":"1.0","type":"link"}